1[2]Authors/Task Force Members:2007 Guidelines for the Management of Arterial Hypertension.The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology(ESC) J Hypertension,2007,25:1105-1187
2[3]The ALLHAT officers and Coordinators for the ALLHAT Collaborative Research Group.Major outcomes in high-risk hypertensive patients randomized to angiotensin converting enzyme inhibitor or diuretic:The Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial (ALLHAT).JAMA,2002,288:2981-2997
3[4]Franz HM,Staessen JA.Amlodipine Better Than Lisinopril?:How One Randomized Clinical Trial Ended Fallacies From Observational Studies.Hypertension,2006,48:359-361
4[5]Nissen SE,Tuzcu EM,Libby P,et al.CAMELOT Investigators.Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure:the CAMELOT study:a randomized controlled trial.JAMA,2004,292:2217-2225
5[6]Dahlof B,Sever PS,Poulter NR,et al.ASCOT Investigators.Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendoflumethiazide as required,in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm(ASCOT-BPLA):A multicenter randomized controlled trial.Lancet,2005,366:895-906
6[7]Pahor M,Psaty BM,Alderman MH,et al.Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes.Diabetes Care,2000,23:888-892
7[8]PROGRASS Collaborative Study Group.Randomised trial of perindopril based blood pressure-lowering regimen among 6108individuals with previous stroke or transient ischemic attack.Lancet,2001,358:1033-1041
8[9]Wachtell K,Lehto M,Gerdts E,et al.Angiotensin Ⅱ receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol:the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.J Am Coll Cardiol,2005,45:712-719
9[10]Maggioni AP,Latini R,Carson PE,et al.Valsartan reduces the incidence of atrial fibrillation in patients with heart failure:results from the Valsartan Heart Failure Trial (Val-HeFT).Am Heart J,2005,149:548-557
10[11]Schmieder R,Kjeldsen SE,Julius S,et al.Reduced incidence of new onset atrial fibrillation with angiotensin Ⅱ receptor blockade:the VALUE-trial.J Hypertens,2006,242:S3 (abstract)